A safe and effective vaccine against strangles is not yet on the market.

Strangvac®, consisting only of soluble recombinant proteins, is injected intramuscularly and totally devoid of any living infectious agent. This results in a well-tolerated vaccine with only mild, local and transient side effects, as expected of a modern vaccine.